734 studies found for:    "bladder cancer"
Show Display Options
Rank Status Study
1 Active, not recruiting Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer;   Bladder Neoplasms
Intervention:
2 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3D conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
3 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
4 Terminated
Has Results
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage 0 Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: broccoli sprout extract;   Other: laboratory biomarker analysis;   Other: Mango Juice
5 Completed
Has Results
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: genistein;   Other: laboratory biomarker analysis;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study
6 Completed Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Procedure: Prostate capsule sparing cystectomy;   Procedure: Nerve sparing cystectomy
7 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Sirolimus;   Procedure: Therapeutic Conventional Surgery
8 Active, not recruiting Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Conditions: Distal Urethral Cancer;   Proximal Urethral Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
9 Terminated Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
Conditions: Urinary Bladder Diseases;   Urinary Bladder Neoplasms;   Urinary Bladder Cancer;   Malignant Tumor of Urinary Bladder;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Site
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
10 Completed
Has Results
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Urothelial Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Paclitaxel;   Biological: Trastuzumab;   Radiation: Radiation Therapy
11 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
12 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
13 Recruiting MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Conditions: No Evidence of Disease;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IVA Bladder Cancer;   Stage IVB Bladder Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
14 Unknown  Quality of Life in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: questionnaire administration
15 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
16 Recruiting 3 Tesla MRI in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: Specimen Ultra-High field MRI;   Drug: chemotherapy;   Procedure: Cystectomy and Lymphadenectomy
17 Unknown  Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
Condition: Bladder Cancer
Interventions: Genetic: loss of heterozygosity analysis;   Genetic: microarray analysis;   Genetic: microsatellite instability analysis;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: cystoscopy
18 Unknown  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: medical chart review;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
19 Completed Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer;   Urinary Cancer;   Nonmuscle Invasive Bladder Cancer
Interventions: Genetic: specimen samples;   Behavioral: questionnaires
20 Completed Eflornithine in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: eflornithine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years